Acquista Criptovalute
Paga con
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Mercati
Trading
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Opzioni
Hot
Trade European-style Vanilla Options
Conto unificato
Massimizza l'efficienza del tuo capitale
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Guadagna
Lancia
CandyDrop
Raccogli le caramelle per guadagnare airdrop
Launchpool
Staking rapido, guadagna potenziali nuovi token
HODLer Airdrop
Fai holding GT e ottieni enormi airdrop gratuitamente
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investimento
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
Altro
Promozioni
AI
Altro
TradFi
WCTC S8
Rewards
VTRS

Prezzo Viatris Inc

Closed
VTRS
$0
+$0(0,00%)
Nessun dato

*Data last updated: 2026-04-29 01:35 (UTC+8)

As of 2026-04-29 01:35, Viatris Inc (VTRS) is priced at $0, with a total market cap of $17,25B, a P/E ratio of -4,14, and a dividend yield of 3,23%. Today, the stock price fluctuated between $0 and $0. The current price is 0,00% above the day's low and 0,00% below the day's high, with a trading volume of 8,77M. Over the past 52 weeks, VTRS has traded between $0 to $0, and the current price is 0,00% away from the 52-week high.

VTRS Key Stats

Yesterday's Close$14
Market Cap$17,25B
Volume8,77M
P/E Ratio-4,14
Dividend Yield (TTM)3,23%
Dividend Amount$0
Diluted EPS (TTM)3,05
Net Income (FY)-$3,51B
Revenue (FY)$14,29B
Earnings Date2026-05-07
EPS Estimate0,52
Revenue Estimate$3,35B
Shares Outstanding1,16B
Beta (1Y)0.822
Ex-Dividend Date2026-03-09
Dividend Payment Date2026-03-18

About VTRS

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOScott Andrew Smith
HeadquartersCanonsburg,PA,US
Official Websitehttps://www.viatris.com
Employees (FY)30,00K
Average Revenue (1Y)$476,66K
Net Income per Employee-$117,16K

Viatris Inc (VTRS) FAQ

What's the stock price of Viatris Inc (VTRS) today?

x
Viatris Inc (VTRS) is currently trading at $0, with a 24h change of 0,00%. The 52-week trading range is $0–$0.

What are the 52-week high and low prices for Viatris Inc (VTRS)?

x

What is the price-to-earnings (P/E) ratio of Viatris Inc (VTRS)? What does it indicate?

x

What is the market cap of Viatris Inc (VTRS)?

x

What is the most recent quarterly earnings per share (EPS) for Viatris Inc (VTRS)?

x

Should you buy or sell Viatris Inc (VTRS) now?

x

What factors can affect the stock price of Viatris Inc (VTRS)?

x

How to buy Viatris Inc (VTRS) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

VTRS
CFD
Fai trading

Hot Posts su Viatris Inc (VTRS)

K-LinePoet

K-LinePoet

04-09 12:55
2026年3月5日， Viatris（VTRS）披露19笔公司内部人交易情况。董事Smith Scott Andrew于2026年3月4日卖出50.64万股。 **【近期内部交易】** | 披露日期 | 职位 | 姓名 | 交易日期 | 买/卖 | 数量 | 每股成交价/美元 | 总金额/美元 | | --- | --- | --- | --- | --- | --- | --- | --- | | 2026年3月5日 | 高管 | Mistras Theodora | 2026年3月4日 | 卖出 | 1.89万 | 14.71 | 27.73万 | | 2026年3月5日 | 高管 | Campbell Paul | 2026年3月4日 | 卖出 | 8198 | 14.71 | 12.06万 | | 2026年3月5日 | 高管 | Le Goff Corinne | 2026年3月4日 | 卖出 | 1.77万 | 14.71 | 25.97万 | | 2026年3月5日 | 高管 | Enrietti Andrew | 2026年3月3日 | 卖出 | 5.40万 | 14.89 | 80.33万 | | 2026年3月5日 | 董事 | Smith Scott Andrew | 2026年3月4日 | 卖出 | 3.98万 | 14.71 | 58.59万 | | 2026年3月5日 | 董事 | Smith Scott Andrew | 2026年3月3日 | 卖出 | 56.70万 | 14.89 | 844.22万 | | 2026年3月5日 | 高管 | Campbell Paul | 2026年3月3日 | 卖出 | 8.33万 | 14.89 | 124.09万 | | 2026年3月5日 | 高管 | Enrietti Andrew | 2026年3月4日 | 卖出 | 6458 | 14.71 | 9.50万 | | 2026年1月2日 | 高管 | Mistras Theodora | 2026年1月1日 | 卖出 | 1.46万 | 12.45 | 18.17万 | | 2025年9月12日 | 高管 | Le Goff Corinne | 2025年9月11日 | 卖出 | 7032 | 10.25 | 7.20万 | **【公司资料】** Viatris Inc.于2019年2月14日在特拉华州成立。该公司是一家全球性的医疗保健公司，该公司认为他们具有独特的定位，可以弥合仿制药和品牌之间的传统鸿沟，将两者的优点结合起来，以更全面地满足全球范围内的医疗保健需求。Viatris的使命是赋能世界各地的人们在生命的每个阶段都能过上更健康的生活，大规模地提供准入服务，目前每年为全球约10亿患者提供高质量的药物，并触及生命的所有时刻，从出生到生命的尽头，从急性病到慢性病。
0
0
0
0
SelfRugger

SelfRugger

04-08 09:10
Stocks Muted Before the Open as Investors Digest Nvidia Earnings, U.S.-Iran Talks in Focus ========================================================================================== Oleksandr Pylypenko Thu, February 26, 2026 at 8:30 PM GMT+9 10 min read In this article: * StockStory Top Pick NVDA -5.27% March S&P 500 E-Mini futures (ESH26) are down -0.05%, andMarch Nasdaq 100 E-Mini futures (NQH26) are down -0.09% this morning, pointing to a muted open on Wall Street as investors digest earnings from AI bellwether Nvidia, while nuclear talks between the U.S. and Iran have begun. Nvidia (NVDA) rose about +0.6% in pre-market trading after the chipmaker posted stronger-than-expected Q4 results and provided Q1 revenue guidance that smashed Wall Street expectations. However, investors delivered a muted response to the chip giant’s results as doubts lingered over whether strong AI sales can be sustained. ### More News from Barchart * As Nvidia Launches New AI Laptop Chips, Should You Buy NVDA Stock? * 3 Highest Rated Dividend Kings for Generations of Income * GE Aerospace Is Linking Up with Palantir. Should You Buy GE Stock Here? * Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Investor attention is now squarely on a third round of high-stakes nuclear talks between the U.S. and Iran in Geneva. The semi-official Iranian Students’ News Agency reported that the two sides are holding negotiations through mediator Oman at its embassy in Geneva. U.S. President Donald Trump had set a March 1-6 deadline for Tehran to reach an agreement and has threatened military strikes if it does not comply. In yesterday’s trading session, Wall Street’s three main equity benchmarks ended in the green. Axon Enterprise (AXON) jumped over +17% and was the top percentage gainer on the S&P 500 and Nasdaq 100 after the maker of Taser stun guns reported upbeat Q4 results and provided strong FY26 revenue growth guidance. Also, cryptocurrency-exposed stocks rallied after Bitcoin climbed more than +7%, with Coinbase Global (COIN) surging over +13% and Strategy (MSTR) gaining more than +8%. In addition, software stocks advanced, with Thomson Reuters (TRI) climbing over +10% and Intuit (INTU) rising more than +6%. On the bearish side, GoDaddy (GDDY) plunged over -14% and was the top percentage loser on the S&P 500 after the domain registrar and web hosting company issued below-consensus FY26 revenue guidance. Kansas City Fed President Jeff Schmid on Wednesday repeated his concerns about inflation but stopped short of outlining how monetary policy should respond. “I think we have work to do on the inflation side of things,” Schmid said. “I think we’re in a pretty good place for employment,” he added. Also, St. Louis Fed President Alberto Musalem said he believes the current U.S. policy rate setting appropriately balances prevailing economic risks. Story Continues Meanwhile, U.S. rate futures have priced in a 98.0% probability of no rate change and a 2.0% chance of a 25 basis point rate cut at the next FOMC meeting in March. In tariff news, U.S. Trade Representative Jamieson Greer said on Wednesday that President Trump will sign a directive in the coming days raising his global tariff to 15% “where appropriate” and is seeking “continuity” with countries that have reached trade deals. Today, investors will focus on U.S. Initial Jobless Claims data, which is set to be released in a couple of hours. Economists expect this figure to be 217K, compared to last week’s number of 206K. Also, Fed Vice Chair for Supervision Michelle Bowman is set to testify today before the Senate Committee on Banking, Housing, and Urban Affairs at a hearing titled “Update from the Prudential Regulators.” On the earnings front, high-profile companies such as Intuit (INTU), Monster Beverage (MNST), Dell Technologies (DELL), Vistra (VST), and CoreWeave (CRWV) are slated to release their quarterly results today. In the bond market, the yield on the benchmark 10-year U.S. Treasury note is at 4.047%, down -0.05%. The Euro Stoxx 50 Index is up +0.30% this morning, hitting a new record high as investors cheered a slew of positive corporate earnings reports. Utility and industrial stocks outperformed on Thursday. Defense stocks also advanced, led by a more than +18% jump in Indra Sistemas Sa (IDR.E.DX) after the company posted upbeat 2025 results. In addition, technology stocks rose following strong results and guidance from AI bellwether Nvidia. The European Commission reported on Thursday that business confidence in the Eurozone weakened in February amid renewed uncertainties over Europe’s political and economic ties with the U.S. Separately, data from the European Central Bank showed that lending to Eurozone businesses slowed in January, while credit to households remained steady. Meanwhile, ECB President Christine Lagarde said on Thursday that the Eurozone economy expanded more quickly last year than the central bank had anticipated, and that growth would be supported in 2026 by stronger household demand as well as increased investment. However, Lagarde said exporters will continue to face headwinds and uncertainty, partly due to shifting policy in the U.S. Investor focus now turns to nuclear talks between the U.S. and Iran in Geneva. In other corporate news, Puma SE (PUM.D.DX) climbed over +4% after reporting a narrower-than-expected annual loss. Also, Schneider Electric SE (SU.FP) rose more than +4% after the company reported better-than-expected core earnings. At the same time, Syensqo (SYENS.BB) cratered over -24% after the Belgian chemicals group posted weaker-than-expected Q4 core earnings. Eurozone’s Business and Consumer Survey and Eurozone’s Consumer Confidence data were released today. Eurozone’s February Business and Consumer Survey stood at 98.3, weaker than expectations of 99.8. Eurozone’s February Consumer Confidence came in at -12.2, in line with expectations. Asian stock markets today settled mixed. China’s Shanghai Composite Index (SHCOMP) closed down -0.01%, and Japan’s Nikkei 225 Stock Index (NIK) closed up +0.29%. China’s Shanghai Composite Index closed just below the flatline today as investors cautiously awaited next week’s annual parliamentary meeting. Property stocks led the declines on Thursday, wiping out all of yesterday’s gains after Shanghai further eased homebuying restrictions. Liquor and energy stocks also slid. Limiting losses, AI-related stocks climbed. Also, lithium stocks rose following reports that Zimbabwe had banned the export of lithium concentrate materials. Meanwhile, UBS Securities Asia said on Thursday that Chinese stocks could climb another 20% as rising inflation expectations translate into stronger earnings. Analysts said more Chinese companies are looking to raise prices this year due to higher input costs, while excess capacity is beginning to show signs of improvement. In the case of rising prices, “the potential share price reaction is weighed towards the upside given low expectations around reflation and low positioning of inflation-related stocks,” according to strategists led by James Wang. Investors are looking ahead to the upcoming sessions of the National People’s Congress and the National Committee of the Chinese People’s Political Consultative Conference for fresh policy signals and guidance. State media reported in late December that the closely watched annual parliamentary session is set to begin on March 5th. Julius Baer’s Sophie Altermatt said China is likely to set a lower economic growth target for 2026 as it transitions from high-speed to high-quality growth, and she expects Beijing to announce a goal of 4.5%-5.0%. Japan’s Nikkei 225 Stock Index closed higher and hit a new record high today, tracking overnight gains on Wall Street. Software stocks led the gains on Thursday as concerns about AI disruption subsided. Financial and energy stocks also advanced. At the same time, chip stocks retreated as investors digested Nvidia’s quarterly results. Yutaka Miura, senior technical analyst at Mizuho Securities, said, “Since it was widely expected that NVIDIA would post strong results, and it did, this has prompted some profit-taking for the moment.” The benchmark index initially climbed more than +1% to break above the 59,000 level for the first time, but gave up most of those gains following hawkish signals from the Bank of Japan. The Yomiuri newspaper reported on Thursday that BOJ Governor Kazuo Ueda said the central bank will closely examine data at its March and April meetings when deciding whether to raise interest rates, keeping the door open for a near-term hike. Also, BOJ board member Hajime Takata, the most hawkish voice on the panel, reiterated calls for additional rate hikes. “I believe the bank should make a further gear shift, and engage in communication that assumes that the price stability target is almost achieved,” Takata said. Meanwhile, the yen and shorter-dated domestic government bond yields rose on Thursday after comments from BOJ officials fueled expectations of an early interest rate hike. On the economic front, data showed that Japan’s December leading economic indicators index, which gauges the economic outlook for a few months ahead based on data such as job offers and consumer sentiment, was revised higher. Investors are awaiting a slew of Japan’s economic data due on Friday, including Tokyo core CPI, industrial production, and retail sales. The Nikkei Volatility Index, which takes into account the implied volatility of Nikkei 225 options, closed up +16.07% to 31.21. The Japanese December Leading Index came in at 111.0, stronger than expectations of 110.2. **Pre-Market U.S. Stock Movers** Nvidia (NVDA) rose about +0.6% in pre-market trading after the chipmaker posted stronger-than-expected Q4 results and provided Q1 revenue guidance that smashed Wall Street expectations. IonQ (IONQ) surged more than +16% in pre-market trading after the quantum-computing company reported much stronger-than-expected Q4 revenue and issued strong FY26 revenue guidance. U.S. Bancorp (USB) gained about +1% in pre-market trading after Truist upgraded the stock to Buy from Hold with a price target of $66. Salesforce (CRM) slid over -3% in pre-market trading after the software maker issued tepid full-year revenue guidance that failed to reassure investors concerned about the threat posed by AI agents. The Trade Desk (TTD) plunged more than -16% in pre-market trading after the advertising technology company provided below-consensus Q1 revenue guidance. _You can see more __pre-market stock movers__ here_ **Today’s U.S. Earnings Spotlight: Thursday - February 26th** Intuit (INTU), Monster Beverage (MNST), Dell Technologies (DELL), Warner Bros. Discovery (WBD), Sempra (SRE), Vistra (VST), CoreWeave (CRWV), Rocket Companies (RKT), Autodesk (ADSK), Cheniere Energy (LNG), Public Service Enterprise Group (PEG), Rocket Lab (RKLB), EMCOR Group (EME), Coupang (CPNG), Block (XYZ), Natera (NTRA), Qnity Electronics (Q), Zscaler (ZS), Coterra Energy (CTRA), Formula One Group (FWONA), MasTec (MTZ), Formula One Group (FWONK), SBA Communications (SBAC), NetApp (NTAP), Viatris (VTRS), Talen Energy (TLN), Hormel Foods (HRL), TopBuild (BLD), Celsius Holdings (CELH), Solventum (SOLV), Donaldson Company (DCI), The AES Corporation (AES), The J. M. Smucker Company (SJM), MP Materials (MP), Bentley Systems (BSY), American Healthcare REIT (AHR), Masimo (MASI), CubeSmart (CUBE), Installed Building Products (IBP), The Middleby Corporation (MIDD), TeraWulf (WULF), Figure Technology Solutions (FIGR), Kymera Therapeutics (KYMR), D-Wave Quantum (QBTS), Nexstar Media Group (NXST), Primo Brands (PRMB), Rhythm Pharmaceuticals (RYTM), Arcosa (ACA), Loar Holdings (LOAR), Elastic (ESTC), OneStream (OS), Acushnet Holdings (GOLF), Energy Fuels (UUUU), Compass (COMP), The Brink's Company (BCO), Main Street Capital (MAIN), KBR, Inc. (KBR), Caris Life Sciences (CAI), Duolingo (DUOL), Millrose Properties (MRP), Shift4 Payments (FOUR), Lantheus Holdings (LNTH), Teleflex (TFX), FTI Consulting (FCN), Nelnet (NNI), Sunrun (RUN), Crinetics Pharmaceuticals (CRNX), Tutor Perini (TPC), ACM Research (ACMR), TG Therapeutics (TGTX), National Health Investors (NHI), Hilton Grand Vacations (HGV), ACI Worldwide (ACIW), Frontdoor (FTDR), Applied Optoelectronics (AAOI), NuScale Power (SMR), Vistance Networks (VISN), Alignment Healthcare (ALHC), Hagerty (HGTY), Assured Guaranty (AGO), Shake Shack (SHAK), Tidewater (TDW), Perimeter Solutions (PRM), Ligand Pharmaceuticals (LGND), Eos Energy Enterprises (EOSE), SoundHound AI (SOUN), International Seaways (INSW), nLIGHT (LASR), MARA Holdings (MARA), Edgewise Therapeutics (EWTX), NCR Atleos (NATL), Ambarella (AMBA), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Warby Parker (WRBY), Wave Life Sciences (WVE), DENTSPLY SIRONA (XRAY), The Baldwin Insurance Group (BWIN), Enerflex (EFXT), AvePoint (AVPT), Grindr (GRND), Walker & Dunlop (WD), DiamondRock Hospitality Company (DRH), Flowco Holdings (FLOC), Nektar Therapeutics (NKTR). _ On the date of publication, Oleksandr Pylypenko did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com _ Terms and Privacy Policy Privacy Dashboard More Info
0
0
0
0
NodeGuardian

NodeGuardian

04-05 08:04
Viatris Inc. recently secured approval in Japan for Effexor SR capsules as the first treatment for generalized anxiety disorder (GAD), expanding its market beyond depression. This move aligns with Viatris's strategy to pivot towards higher-value, innovative medicines from commoditized generics, reinforcing its investment narrative for gradually improving earnings. While promising, this approval alone doesn't shift the immediate focus on cost savings and managing margin pressures in its core generics business.
0
0
0
0